| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP Research &Development | Director
3 companies
Malik Fady Ibraham serves as an EVP Research &Development at CYTK and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 0 buys and 109 sells. Those positions are worth an estimated $11.9M at current prices.
Historically, Malik Fady Ibraham's trades have earned a middling insider score of 55/100 across 77 rated trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -29.7%.
The biggest single holding is CYTK (~$11.8M) as EVP Research &Development. The recent filings there lean toward selling, a net 574,726 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 12, 2023 | CYTK Cytokinetics Inc | EVP Research &Development | Sell | 4,000 | $40.47 | $161,880.00 | -2.5% | -20.5% | +99.9% | |
| Dec 8, 2022 | CYTK Cytokinetics Inc | EVP Research &Development | Sell | 4,000 | $36.28 | $145,120.00 | -2.4% | +9.0% | -5.3% | |
| Nov 10, 2022 | CYTK Cytokinetics Inc | EVP Research &Development | Sell | 4,000 | $38.04 | $152,160.00 | -2.4% | +12.2% | -16.9% | |
| Oct 13, 2022 | CYTK Cytokinetics Inc | EVP Research &Development | Sale+OE | 21,513 | $47.28 | $1,017,134.64 | -11.3% | -15.2% | -29.7% | |
| Sep 8, 2022 | CYTK Cytokinetics Inc | EVP Research &Development | Sale+OE | 21,500 | $51.88 | $1,115,420.00 | -11.3% | -31.5% | -33.3% | |
| Jul 14, 2022 | CYTK Cytokinetics Inc | EVP Research &Development | Sale+OE | 21,500 | $43.43 | $933,745.00 | -11.3% | +11.1% | -19.1% | |
| Jun 9, 2022 | CYTK Cytokinetics Inc | EVP Research &Development | Sale+OE | 21,500 | $40.62 | $873,330.00 | -11.3% | +31.3% | -4.7% | |
| May 12, 2022 | CYTK Cytokinetics Inc | EVP Research &Development | Sale+OE | 13,987 | $37.54 | $525,074.78 | -7.7% | +37.5% | -1.9% | |
| Apr 7, 2022 | CYTK Cytokinetics Inc | EVP Research &Development | Sale+OE | 23,148 | $42.58 | $985,755.27 | -12.1% | +2.2% | -15.7% | |
| Mar 10, 2022 | CYTK Cytokinetics Inc | EVP Research &Development | Sale+OE | 26,852 | $37.82 | $1,015,462.08 | -13.8% | +10.1% | -6.0% |